{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:21:00Z","timestamp":1792696860349,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00018-023-04905-6","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T10:03:13Z","timestamp":1692007393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9967-1546","authenticated-orcid":false,"given":"Tom C.","family":"Karagiannis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Ververis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Pitsillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haloom","family":"Rafehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishant","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott S.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitraporn","family":"Vongsvivut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assam","family":"El-Osta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"4905_CR1","first-page":"1497","volume":"132","author":"PC Nowell","year":"1960","unstructured":"Nowell PC (1960) A minute chromosome in human granulocytic leukemia. Science 132:1497\u20131501","journal-title":"Science"},{"issue":"3","key":"4905_CR2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","volume":"45","author":"CB Lozzio","year":"1975","unstructured":"Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45(3):321\u2013334","journal-title":"Blood"},{"issue":"3","key":"4905_CR3","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1124\/jpet.107.124461","volume":"322","author":"SM Lee","year":"2007","unstructured":"Lee SM, Bae JH, Kim MJ et al (2007) Bcr-Abl-independent imatinib-resistant K562 cells show aberrant protein acetylation and increased sensitivity to histone deacetylase inhibitors. J Pharmacol Exp Ther 322(3):1084\u20131092","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"4905_CR4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","volume":"17","author":"B Zhang","year":"2010","unstructured":"Zhang B, Strauss AC, Chu S et al (2010) Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell 17(5):427\u2013442","journal-title":"Cancer Cell"},{"issue":"5","key":"4905_CR5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E et al (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2(5):561\u2013566","journal-title":"Nat Med"},{"issue":"1","key":"4905_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/leu.2010.238","volume":"25","author":"D Bixby","year":"2011","unstructured":"Bixby D, Talpaz M (2011) Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia. Leukemia 25(1):7\u201322","journal-title":"Leukemia"},{"issue":"5","key":"4905_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc2126","volume":"7","author":"E Weisberg","year":"2007","unstructured":"Weisberg E, Manley PW, Cowan-Jacob SW, Hochhaus A, Griffin JD (2007) Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat Rev Cancer 7(5):345\u2013356","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4905_CR8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szak\u00e1cs","year":"2006","unstructured":"Szak\u00e1cs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5(3):219\u2013234","journal-title":"Nat Rev Drug Discov"},{"key":"4905_CR9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/281709b0","volume":"281","author":"CB Lozzio","year":"1979","unstructured":"Lozzio CB, Lozzio BB, Machado EA, Fuhr JE, Lair SV, Bamberger EG (1979) Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K562. Nature 281:709\u2013710","journal-title":"Nature"},{"issue":"8","key":"4905_CR10","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2002-08-2675","volume":"101","author":"R Nimmanapalli","year":"2003","unstructured":"Nimmanapalli R, Fuino L, Stobaugh C, Richon V, Bhalla K (2003) Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl\u2013positive human acute leukemia cells. Blood 101(8):3236\u20133239","journal-title":"Blood"},{"issue":"8","key":"4905_CR11","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1073\/pnas.80.8.2263","volume":"80","author":"RD Klausner","year":"1983","unstructured":"Klausner RD, Ashwell G, Van Renswoude J, Harford JB, Bridges KR (1983) Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc Natl Acad Sci 80(8):2263\u20132266","journal-title":"Proc Natl Acad Sci"},{"issue":"20","key":"4905_CR12","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1073\/pnas.79.20.6186","volume":"79","author":"J Van Renswoude","year":"1982","unstructured":"Van Renswoude J, Bridges KR, Harford JB, Klausner RD (1982) Receptor-mediated endocytosis of transferrin and the uptake of Fe in K562 cells: identification of a nonlysosomal acidic compartment. Proc Natl Acad Sci 79(20):6186\u20136190","journal-title":"Proc Natl Acad Sci"},{"issue":"21","key":"4905_CR13","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1158\/0008-5472.CAN-06-1853","volume":"66","author":"TC Karagiannis","year":"2006","unstructured":"Karagiannis TC, Lobachevsky PN, Leung BK, White JM, Martin RF (2006) Receptor-mediated DNA-targeted photoimmunotherapy. Can Res 66(21):10548\u201310552","journal-title":"Can Res"},{"issue":"7291","key":"4905_CR14","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature08956","volume":"464","author":"ME Davis","year":"2010","unstructured":"Davis ME, Zuckerman JE, Choi CH et al (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291):1067\u20131070. https:\/\/doi.org\/10.1038\/nature08956","journal-title":"Nature"},{"key":"4905_CR15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/B978-0-12-427150-0.50098-X","volume-title":"Hemocytometer counting. Tissue culture: methods and applications","author":"M Absher","year":"1973","unstructured":"Absher M (1973) Hemocytometer counting. Tissue culture: methods and applications. Academic Press, New York, pp 395\u2013397"},{"issue":"2","key":"4905_CR16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s12263-011-0249-3","volume":"7","author":"H Rafehi","year":"2012","unstructured":"Rafehi H, Smith AJ, Balcerczyk A et al (2012) Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis. Genes Nutr 7(2):343\u2013355","journal-title":"Genes Nutr"},{"key":"4905_CR17","unstructured":"Tang A, Team AP (2014) Functional genomics data and expression look-up tools: array express and expression atlas"},{"issue":"4","key":"4905_CR18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nbt0410-322","volume":"28","author":"M Lukk","year":"2010","unstructured":"Lukk M, Kapushesky M, Nikkil\u00e4 J et al (2010) A global map of human gene expression. Nat Biotechnol 28(4):322\u2013324","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4905_CR19","doi-asserted-by":"crossref","first-page":"C125","DOI":"10.1152\/ajpcell.00247.2006","volume":"292","author":"M Wu","year":"2007","unstructured":"Wu M, Neilson A, Swift AL et al (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292(1):C125\u2013C136","journal-title":"Am J Physiol Cell Physiol"},{"key":"4905_CR20","doi-asserted-by":"publisher","DOI":"10.3791\/1957","author":"L-J Mah","year":"2010","unstructured":"Mah L-J, Vasireddy RS, Tang MM, Georgiadis GT, El-Osta A, Karagiannis TC (2010) Quantification of \u03b3H2AX Foci in Response to Ionising Radiation. J Visualiz Exp. https:\/\/doi.org\/10.3791\/1957","journal-title":"J Visualiz Exp"},{"issue":"24","key":"4905_CR21","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1007\/s00018-011-0727-1","volume":"68","author":"K Ververis","year":"2011","unstructured":"Ververis K, Rodd AL, Tang MM, El-Osta A, Karagiannis TC (2011) Histone deacetylase inhibitors augment doxorubicin-induced DNA damage in cardiomyocytes. Cell Mol Life Sci 68(24):4101\u20134114. https:\/\/doi.org\/10.1007\/s00018-011-0727-1","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"4905_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ijc.2910230202","volume":"23","author":"LC Andersson","year":"1979","unstructured":"Andersson LC, Nilsson K, Gahmberg CG (1979) K562\u2014a human erythroleukemic cell line. Int J Cancer 23(2):143\u2013147","journal-title":"Int J Cancer"},{"issue":"3","key":"4905_CR23","first-page":"250","volume":"5","author":"JA Sutherland","year":"1986","unstructured":"Sutherland JA, Turner AR, Mannoni P, McGann LE, Turc JM (1986) Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J Biol Response Mod 5(3):250\u2013262","journal-title":"J Biol Response Mod"},{"issue":"6","key":"4905_CR24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2184.1993.tb00030.x","volume":"26","author":"BS Baliga","year":"1993","unstructured":"Baliga BS, Mankad M, Shah AK, Mankad VN (1993) Mechanism of differentiation of human erythroleukaemic cell line K562 by hemin. Cell Prolif 26(6):519\u2013529","journal-title":"Cell Prolif"},{"key":"4905_CR25","first-page":"419","volume-title":"FTIR imaging of tissues: techniques and methods of analysis. Optical spectroscopy and computational methods in biology and medicine","author":"K Malek","year":"2014","unstructured":"Malek K, Wood BR, Bambery KR (2014) FTIR imaging of tissues: techniques and methods of analysis. Optical spectroscopy and computational methods in biology and medicine. Springer, pp 419\u2013473"},{"issue":"2","key":"4905_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/05704920701829043","volume":"43","author":"Z Movasaghi","year":"2008","unstructured":"Movasaghi Z, Rehman S, ur Rehman DI (2008) Fourier transform infrared (FTIR) spectroscopy of biological tissues. Appl Spectrosc Rev 43(2):134\u2013179","journal-title":"Appl Spectrosc Rev"},{"issue":"12","key":"4905_CR27","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1039\/c0an00509f","volume":"135","author":"G Bellisola","year":"2010","unstructured":"Bellisola G, Della Peruta M, Vezzalini M et al (2010) Tracking infrared signatures of drugs in cancer cells by Fourier transform microspectroscopy. Analyst 135(12):3077\u20133086","journal-title":"Analyst"},{"issue":"1","key":"4905_CR28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-4608(85)90101-3","volume":"17","author":"TR Chen","year":"1985","unstructured":"Chen TR (1985) Modal karyotype of human leukemia cell line, K562 (ATCC CCL 243). Cancer Genet Cytogenet 17(1):55\u201360","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"4905_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(99)00169-7","volume":"118","author":"SM Gribble","year":"2000","unstructured":"Gribble SM, Roberts I, Grace C, Andrews KM, Green AR, Nacheva EP (2000) Cytogenetics of the chronic myeloid leukemia-derived cell line K562: karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization. Cancer Genet Cytogenet 118(1):1\u20138","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"4905_CR30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0145-2126(00)00125-9","volume":"25","author":"S Naumann","year":"2001","unstructured":"Naumann S, Reutzel D, Speicher M, Decker HJ (2001) Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization. Leuk Res 25(4):313\u2013322","journal-title":"Leuk Res"},{"issue":"4","key":"4905_CR31","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ijc.2910240422","volume":"24","author":"LC Andersson","year":"1979","unstructured":"Andersson LC, Jokinen M, Gahmberg CG, Klein E, Klein G, Nilsson K (1979) Presence of erythrocytic components in the K562 cell line. Int J Cancer 24(4):514","journal-title":"Int J Cancer"},{"key":"4905_CR32","first-page":"509","volume":"165","author":"A Cudkowicz","year":"1983","unstructured":"Cudkowicz A, Klausner R, Bridges K (1983) Regulation of the transferrin receptor in K562 erythroleukemia cells. Prog Clin Biol Res 165:509\u2013519","journal-title":"Prog Clin Biol Res"},{"issue":"3","key":"4905_CR33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood.V65.3.526.526","volume":"65","author":"D Leibowitz","year":"1985","unstructured":"Leibowitz D, Cubbon R, Bank A (1985) Increased expression of a novel c-abl-related RNA in K562 cells. Blood 65(3):526\u2013529","journal-title":"Blood"},{"issue":"2","key":"4905_CR34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0161-5890(90)90108-C","volume":"27","author":"RT Maziarz","year":"1990","unstructured":"Maziarz RT, Burakoff SJ, Faller DV (1990) The regulation of exogenous and endogenous class I MHC genes in a human tumor cell line, K562. Mol Immunol 27(2):135\u2013142","journal-title":"Mol Immunol"},{"issue":"4603","key":"4905_CR35","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.6574602","volume":"220","author":"P Charnay","year":"1983","unstructured":"Charnay P, Maniatis T (1983) Transcriptional regulation of globin gene expression in the human erythroid cell line K562. Science 220(4603):1281\u20131283","journal-title":"Science"},{"issue":"43","key":"4905_CR36","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545\u201315550","journal-title":"Proc Natl Acad Sci USA"},{"key":"4905_CR37","volume":"40","author":"M Kanehisa","year":"2011","unstructured":"Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M (2011) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic acids Res 40:gkr988","journal-title":"Nucleic acids Res"},{"issue":"suppl 1","key":"4905_CR38","doi-asserted-by":"crossref","first-page":"D258","DOI":"10.1093\/nar\/gkh036","volume":"32","author":"Consortium GO","year":"2004","unstructured":"Consortium GO (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32(suppl 1):D258\u2013D261","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"4905_CR39","first-page":"9","volume":"9","author":"L del Senno","year":"1985","unstructured":"del Senno L, Barbieri R, Amelotti F et al (1985) Methylation and expression of c-myc and c-abl oncogenes in human leukemic K562 cells before and after treatment with 5-azacytidine. Cancer Detect Prev 9(1\u20132):9\u201315","journal-title":"Cancer Detect Prev"},{"issue":"16","key":"4905_CR40","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1089\/ars.2014.6096","volume":"22","author":"SM Tortorella","year":"2015","unstructured":"Tortorella SM, Hung A, Karagiannis TC (2015) The implication of cancer progenitor cells and the role of epigenetics in the development of novel therapeutic strategies for chronic myeloid leukemia. Antioxid Redox Signal 22(16):1425\u20131462","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"4905_CR41","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1073\/pnas.76.12.6406","volume":"76","author":"TA Hamilton","year":"1979","unstructured":"Hamilton TA, Wada HG, Sussman HH (1979) Identification of transferrin receptors on the surface of human cultured cells. Proc Natl Acad Sci 76(12):6406\u20136410","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"4905_CR42","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1749-6632.1949.tb27297.x","volume":"51","author":"G Scatchard","year":"1949","unstructured":"Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51(4):660\u2013672","journal-title":"Ann N Y Acad Sci"},{"key":"4905_CR43","doi-asserted-by":"publisher","DOI":"10.1139\/gen-2023-0011","author":"N Fatemiyan","year":"2023","unstructured":"Fatemiyan N, Davie JR (2023) Broad histone H4 monomethylation marks expressed genes involved in translation. Genome. https:\/\/doi.org\/10.1139\/gen-2023-0011","journal-title":"Genome"},{"key":"4905_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182830","author":"P Sharma","year":"2022","unstructured":"Sharma P, Sattarifard H, Fatemiyan N, Lakowski TM, Davie JR (2022) Bioinformatic analyses of Broad H3K79me2 domains in different Leukemia cell line data sets. Cells. https:\/\/doi.org\/10.3390\/cells11182830","journal-title":"Cells"},{"issue":"7","key":"4905_CR45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","volume":"57","author":"D Gewirtz","year":"1999","unstructured":"Gewirtz D (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57(7):727\u2013741","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"4905_CR46","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0006-2952(96)00042-1","volume":"51","author":"M Praet","year":"1996","unstructured":"Praet M, Stryckmans P, Ruysschaert J-M (1996) Cellular uptake, cytotoxicity, and transport kinetics of anthracyclines in human sensitive and multidrug-resistant K562 cells. Biochem Pharmacol 51(10):1341\u20131348","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"4905_CR47","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1366\/0003702971941304","volume":"51","author":"E Benedetti","year":"1997","unstructured":"Benedetti E, Bramanti E, Papineschi F, Rossi I, Benedetti E (1997) Determination of the relative amount of nucleic acids and proteins in leukemic and normal lymphocytes by means of Fourier transform infrared microspectroscopy. Appl Spectrosc 51(6):792\u2013797","journal-title":"Appl Spectrosc"},{"issue":"6","key":"4905_CR48","first-page":"2905","volume":"43","author":"T Tsuruo","year":"1983","unstructured":"Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y (1983) Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Can Res 43(6):2905\u20132910","journal-title":"Can Res"},{"issue":"2","key":"4905_CR49","first-page":"277","volume":"3","author":"B Chen","year":"2008","unstructured":"Chen B, Sun Q, Wang X et al (2008) Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562\/A02 leukemic cells. Int J Nanomed 3(2):277","journal-title":"Int J Nanomed"},{"issue":"3","key":"4905_CR50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/sj.leu.2404549","volume":"21","author":"E Diaz-Blanco","year":"2007","unstructured":"Diaz-Blanco E, Bruns I, Neumann F et al (2007) Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia 21(3):494\u2013504. https:\/\/doi.org\/10.1038\/sj.leu.2404549","journal-title":"Leukemia"},{"key":"4905_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exphem.2016.11.005","volume":"47","author":"CJ Clarke","year":"2017","unstructured":"Clarke CJ, Holyoake TL (2017) Preclinical approaches in chronic myeloid leukemia: from cells to systems. Exp Hematol 47:13\u201323. https:\/\/doi.org\/10.1016\/j.exphem.2016.11.005","journal-title":"Exp Hematol"},{"issue":"49","key":"4905_CR52","doi-asserted-by":"crossref","first-page":"38135","DOI":"10.1074\/jbc.C000664200","volume":"275","author":"AP West","year":"2000","unstructured":"West AP, Bennett MJ, Sellers VM, Andrews NC, Enns CA, Bjorkman PJ (2000) Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem 275(49):38135\u201338138","journal-title":"J Biol Chem"},{"issue":"3","key":"4905_CR53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbagen.2011.09.009","volume":"1820","author":"KM Mayle","year":"2012","unstructured":"Mayle KM, Le AM, Kamei DT (2012) The intracellular trafficking pathway of transferrin. Biochimica et Biophysica Acta (BBA)-General Subjects 1820(3):264\u2013281","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"key":"4905_CR54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394390-3.00001-X","volume":"69","author":"AN Luck","year":"2011","unstructured":"Luck AN, Mason AB (2011) Transferrin-mediated cellular iron delivery. Curr Top Membr 69:3\u201335","journal-title":"Curr Top Membr"},{"issue":"3","key":"4905_CR55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbagen.2011.06.003","volume":"1820","author":"AN Steere","year":"2012","unstructured":"Steere AN, Byrne SL, Chasteen ND, Mason AB (2012) Kinetics of iron release from transferrin bound to the transferrin receptor at endosomal pH. Biochimica et Biophysica Acta (BBA)-General Subjects 1820(3):326\u2013333","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"issue":"5","key":"4905_CR56","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jcp.36.5.539","volume":"36","author":"KC Gatter","year":"1983","unstructured":"Gatter KC, Brown G, Trowbridge I, Woolston R, Mason D (1983) Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 36(5):539\u2013545","journal-title":"J Clin Pathol"},{"key":"4905_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143300","author":"G Poudel","year":"2022","unstructured":"Poudel G, Tolland MG, Hughes TP, Pagani IS (2022) Mechanisms of resistance and implications for treatment strategies in chronic myeloid Leukaemia. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14143300","journal-title":"Cancers (Basel)"},{"issue":"7","key":"4905_CR58","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.18632\/aging.102992","volume":"12","author":"HW Wang","year":"2020","unstructured":"Wang HW, Ma KL, Liu H, Zhou JY (2020) Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen. Aging (Albany NY) 12(7):6018\u20136029. https:\/\/doi.org\/10.18632\/aging.102992","journal-title":"Aging (Albany NY)"},{"key":"4905_CR59","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.2147\/ijn.S51745","volume":"8","author":"W Ding","year":"2013","unstructured":"Ding W, Guo L (2013) Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery. Int J Nanomed 8:4631\u20134639. https:\/\/doi.org\/10.2147\/ijn.S51745","journal-title":"Int J Nanomed"},{"key":"4905_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114442","volume":"238","author":"YL Pan","year":"2022","unstructured":"Pan YL, Zeng SX, Hao RR, Liang MH, Shen ZR, Huang WH (2022) The progress of small-molecules and degraders against BCR-ABL for the treatment of CML. Eur J Med Chem 238:114442. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114442","journal-title":"Eur J Med Chem"},{"issue":"5","key":"4905_CR61","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.hoc.2011.09.004","volume":"25","author":"E Jabbour","year":"2011","unstructured":"Jabbour E, Parikh SA, Kantarjian H, Cortes J (2011) Chronic myeloid leukemia: mechanisms of resistance and treatment. Hematol Oncol Clin North Am 25(5):981\u2013995. https:\/\/doi.org\/10.1016\/j.hoc.2011.09.004. (v)","journal-title":"Hematol Oncol Clin North Am"},{"key":"4905_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113698","volume":"173","author":"M Lernoux","year":"2020","unstructured":"Lernoux M, Schnekenburger M, Dicato M, Diederich M (2020) Epigenetic mechanisms underlying the therapeutic effects of HDAC inhibitors in chronic myeloid leukemia. Biochem Pharmacol 173:113698. https:\/\/doi.org\/10.1016\/j.bcp.2019.113698","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"4905_CR63","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/sj.bjc.6605293","volume":"101","author":"PN Munster","year":"2009","unstructured":"Munster PN, Marchion D, Thomas S et al (2009) Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker. Br J Cancer 101(7):1044\u20131050. https:\/\/doi.org\/10.1038\/sj.bjc.6605293","journal-title":"Br J Cancer"},{"issue":"3","key":"4905_CR64","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1182\/blood-2007-10-116376","volume":"112","author":"Y Dai","year":"2008","unstructured":"Dai Y, Chen S, Venditti CA et al (2008) Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylate. Blood 112(3):793\u2013804. https:\/\/doi.org\/10.1182\/blood-2007-10-116376","journal-title":"Blood"},{"issue":"19","key":"4905_CR65","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/1078-0432.Ccr-06-0980","volume":"12","author":"W Fiskus","year":"2006","unstructured":"Fiskus W, Pranpat M, Balasis M et al (2006) Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells. Clin Cancer Res 12(19):5869\u20135878. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-0980","journal-title":"Clin Cancer Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-04905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-04905-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-04905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T17:16:28Z","timestamp":1694452588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-04905-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4905"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-04905-6","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"9 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Human peripheral blood mononuclear cells (PBMC) were fractionated using the Ficoll Plaque (GE Healthcare, Wauwatosa, Wisconsin, USA) method from buffy coat obtained from the Australian Red Cross Blood Bank (ARCB) under ethics approval (#304\/12) and informed consent was obtained from the donors. Cells were maintained in complete-RPMI-1640 medium supplemented with 10% FBS, 2\u00a0mM <scp>l<\/scp>-glutamine and 1% penicillin\/streptomycin at 37\u00a0\u00b0C, 5% (<i>v<\/i>\/<i>v<\/i>) CO<sub>2<\/sub>.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all donors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from study participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"248"}}